相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The expression of anti-protein disulfide isomerase A3 autoantibody is associated with the increased risk of miscarriage in euthyroid women with thyroid autoimmunity
Zheng Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
Sreya Bagchi et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
PDIA3: Structure, functions and its potential role in viral infections
Faisal Mahmood et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
PDI-Regulated Disulfide Bond Formation in Protein Folding and Biomolecular Assembly
Jiahui Fu et al.
MOLECULES (2021)
A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients
Zewei Tu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy
Lauren E. Powell et al.
CANCER MEDICINE (2021)
Cytokines, Hormones and Cellular Regulatory Mechanisms Favoring Successful Reproduction
Marie-Pierre Piccinni et al.
FRONTIERS IN IMMUNOLOGY (2021)
Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients
Kunjian Lei et al.
FRONTIERS IN ONCOLOGY (2021)
Multi-Omics Data Integration Analysis of an Immune-Related Gene Signature in LGG Patients With Epilepsy
Quan Cheng et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment
Dongqing Sun et al.
NUCLEIC ACIDS RESEARCH (2021)
Inhibitor for protein disulfide-isomerase family A member 3 enhances the antiproliferative effect of inhibitor for mechanistic target of rapamycin in liver cancer: An in vitro study on combination treatment with everolimus and 16F16
Yohei Kaneya et al.
ONCOLOGY LETTERS (2021)
Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis
Julia A. Braun et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
Claudia X. Dominguez et al.
CANCER DISCOVERY (2020)
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian et al.
SCIENCE (2020)
Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas
Qing Hu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
PDIA3 correlates with clinical malignant features and immune signature in human gliomas
Hao Zhang et al.
AGING-US (2020)
Treatment of Neuroblastoma Cells with Inhibitors of Protein Disulfide Isomerase Upregulates NQO1 Activity
Dennis Ozcelik
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
Christopher A. Chuckran et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Functional genomic landscape of cancer-intrinsic evasion of killing by T cells
Keith A. Lawson et al.
NATURE (2020)
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation
Marta Chiavari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Neutrophil diversity and plasticity in tumour progression and therapy
Sebastien Jaillon et al.
NATURE REVIEWS CANCER (2020)
PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
Fatemeh K. Dermani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Downregulation of protein disulfide-isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma
Ryota Kondo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Hao Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma
Lupeng Ye et al.
NATURE BIOTECHNOLOGY (2019)
Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop
Yan Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma
Reeder M. Robinson et al.
LEUKEMIA (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer
Jing Zhou et al.
THERANOSTICS (2019)
Inhibition of protein disulfide isomerase in glioblastoma causes marked downregulation of DNA repair and DNA damage response genes
Shili Xu et al.
THERANOSTICS (2019)
P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas
Hecun Zou et al.
ONCOLOGY REPORTS (2018)
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity
Flavia Giamogante et al.
BIOCHIMIE (2018)
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta et al.
CELL (2018)
Discovery and Mechanistic Elucidation of a Class of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma
Anahita Kyani et al.
CHEMMEDCHEM (2018)
Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease
Xiao Zhou et al.
HUMAN MOLECULAR GENETICS (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Downregulation of PDIA3 inhibits proliferation and invasion of human acute myeloid leukemia cells
Qidong Ye et al.
ONCOTARGETS AND THERAPY (2018)
Expression of protein disulfide isomerase A3 precursor in colorectal cancer
Zhaowei Yang et al.
ONCOTARGETS AND THERAPY (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
Emerging roles of protein disulfide isomerase in cancer
Eunyoug Lee et al.
BMB REPORTS (2017)
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Elodie Picarda et al.
CLINICAL CANCER RESEARCH (2016)
Increased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinoma
Hideyuki Takata et al.
ONCOLOGY LETTERS (2016)
Protein disulfide-isomerase, a folding catalyst and a redox-regulated chaperone
Lei Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Structures and functions of protein disulfide isomerase family members involved in proteostasis in the endoplasmic reticulum
Masaki Okumura et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Protein disulfide isomerase: a promising target for cancer therapy
Shili Xu et al.
DRUG DISCOVERY TODAY (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Direct Estradiol and Diethylstilbestrol Actions on Early-Versus Late-Stage Prostate Cancer Cells
Luke Y. Koong et al.
PROSTATE (2014)
Diethylstilboestrol-A long-term legacy
R. M. Harris et al.
MATURITAS (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment
Shili Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Substrate Specificity of the Oxidoreductase ERp57 Is Determined Primarily by Its Interaction with Calnexin and Calreticulin
Catherine E. Jessop et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Innovation - The Connectivity Map: a new tool for biomedical research
Justin Lamb
NATURE REVIEWS CANCER (2007)
Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain
SJ Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Proteins of the PDI family: Unpredicted non-ER locations and functions
C Turano et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
分享论文
